NCT03484923 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

NCT ID	NCT03484923
Title	Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma (PLATforM)
Acronym	PLATforM
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Novartis Pharmaceuticals
Indications	melanoma
Therapies	Ieramilimab + Spartalizumab Capmatinib + Spartalizumab Canakinumab + Spartalizumab
Age Groups:	senior \| adult
Covered Countries	USA \| NLD \| ITA \| GBR \| FRA \| ESP \| DEU \| CHE \| CAN \| AUS

Filter rows:

Showing 1 to 30 of 30 entries

Facility	City	State	Zip	Country	Details
Massachusetts General Hospital Massachusetts Gen. Hospital CC	Boston	Massachusetts	02114	United States	Details
Novartis Investigative Site	North Sydney	New South Wales	2060	Australia	Details
Novartis Investigative Site	Westmead	New South Wales	2145	Australia	Details
Novartis Investigative Site	Toronto	Ontario	M5G 2M9	Canada	Details
Novartis Investigative Site	Montreal	Quebec	H3T 1E2	Canada	Details
Novartis Investigative Site	Marseille		13009	France	Details
Novartis Investigative Site	Paris 10		75475	France	Details
Novartis Investigative Site	Villejuif		94800	France	Details
Novartis Investigative Site	Dresden		01307	Germany	Details
Novartis Investigative Site	Essen		45147	Germany	Details
Novartis Investigative Site	Hamburg		20246	Germany	Details
Novartis Investigative Site	Kiel		24105	Germany	Details
Novartis Investigative Site	Muenchen		81377	Germany	Details
Novartis Investigative Site	Bergamo	BG	24127	Italy	Details
Novartis Investigative Site	Milano	MI	20133	Italy	Details
Novartis Investigative Site	Napoli		80131	Italy	Details
Novartis Investigative Site	Amsterdam		1066 CX	Netherlands	Details
Novartis Investigative Site	Rotterdam		3015 GD	Netherlands	Details
Novartis Investigative Site	Barcelona	Catalunya	08036	Spain	Details
Novartis Investigative Site	Hospitalet de LLobregat	Catalunya	08907	Spain	Details
Novartis Investigative Site	Madrid		28009	Spain	Details
Novartis Investigative Site	Zuerich		8091	Switzerland	Details
Novartis Investigative Site	Northwood	Middlesex	HA6 2RN	United Kingdom	Details
Novartis Investigative Site	London		SW3 6JJ	United Kingdom	Details
Novartis Investigative Site	Manchester		M20 4BX	United Kingdom	Details
NYU Laura and Isaac Perlmutter Cancer Center Perlmutter Cancer Center	New York	New York	10016	United States	Details
The Angeles Clinic and Research Institute	Los Angeles	California	90025	United States	Details
UCSF Medical Center .	San Francisco	California	94143	United States	Details
University of California Los Angeles	Los Angeles	California	90095	United States	Details
University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	15232	United States	Details

Showing 1 to 30 of 30 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT03484923
Clinical Trial Detail

Contact

NCT03484923Clinical Trial Detail

Contact

NCT03484923
Clinical Trial Detail